T-Mobile Surprises as Tech Winner in Tough Stock Market

Business Wire

Resilience Announces Collaboration to Manufacture and Deliver Biotherapeutics for Rare and Complex Conditions

SAN DIEGO, August 15, 2022–National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access to complex medicines, today announced a strategic collaboration with Mayo Clinic in biomanufacturing to deliver novel biotherapeutics for rare and complex conditions. The focus will be on therapies derived from biologics — cells, blood, enzymes, tissues, genes, or genetically engineered cells — for use in medicines.

Leave a Reply

Your email address will not be published. Required fields are marked *